Florian Maria WurmFlorian Wurm received his academic training as a Biologist and Molecular Geneticist at the University of Giessen. He joined the Hoechst AG (Behringwerke) in Marburg as head of a laboratory in Virology. Working with immortalized mammalian cells for the establishment of production processes for alpha-interferons provided the first opportunity to combine basic research with medical application. In 1984 he joined Harvard Medical School in Boston as a Research Fellow in Molecular Biology. 1986 he took an offer from Genentech Inc. in San Francisco to work in Process Sciences on the development of large scale manufacturing processes for recombinant proteins. There he has held a number of leading positions and has acquired intimate knowledge in the generation of protein pharmaceuticals in mammalian cells in bioreactors (a number of which are now marketed products). In 1995 he joined the EPFL as a Professor for Biotechnology. Wurm has published more than 250 scientific papers and holds more than 20 patents/patent-applications. His H-index stands at 60 in 2021. He was Chairman (2005-2009) and is member of the Executive Board of the European Society of Animal Cell Technology (ESACT). He serves as a consultant to the pharmaceutical Biotech Industry, mainly in the fields of animal cell technology for recombinant protein production and in regulatory affairs. He works as a scientific reviewer and editior/asscciate editor for a number of international journals in the Biotech field. F.M. Wurm teaches classes to pre- and postgraduate students in the fields of Molecular and Cellular Biotechnology.
He was founder and Chief Scientific Officer of ExcellGene SA, a 2001 established company in Monthey, Switzerland. He took the position of President and CEO of ExcellGene in 2015. He retired from the CEO position in 2017 and continues to be President and Chief Scientific Officer of ExcellGene.
In 2008 Dr. Wurm was appointed Visiting Professor for Biotechnology at Jinan University in Guangzhou, China. He retired from his position at the EPFL in 2015. His laboratory is closed. With his team at ExcellGene and in collaboration with Dr. Paco Pino, Director of R&D, he continues to explore manufacturing sciences with animal cells in bioreactors.
Jean-Jacques MeisterA Swiss citizen, Jean-Jacques Meister was born in 1950. He received a diploma in electrical engineering, then a diploma in physics from the Swiss Federal Institute of Technology in Lausanne (EPFL). He joined the Institute of Biomedical Engineering at the Swiss Federal Institute of Technology in Zurich and obtained a PhD in1983. From 1984 to 1990, he worked in different areas of biophysics and biomedical engineering. His main contributions concern novel noninvasive methods for the prevention and diagnosis of cardiovascular diseases: mechanical properties of the arterial wall, arterial hemodynamics, and Doppler ultrasonography. In 1990, he was recruited as a full professor of experimental physics at the Swiss Federal Institute of Technology in Lausanne. He was director of the laboratory of biomedical engineering until 2001, then director of the laboratory of cell biophysics. His fields of research are cellular biophysics: cytoskeleton dynamics, motility & adhesion of cells and calcium dynamics in smooth muscle cells. He spent a sabbatical leave in 2000 at the famous Marine Biological Laboratory, Woods Hole, Massachusetts -USA to improve his skills in molecular and cellular biology. His teaching activities include courses in general physics, Newtonian mechanics, biomedical engineering and biophysics presented to undergraduate and graduate EPFL students in physics and engineering. He is author or co-author of more than 230 scientific papers & book chapters and 8 international patents.
Stewart ColeProfessor Stewart Cole is an international authority in bacterial molecular-genetics and genomics. He has made outstanding contributions in several fields including: bacterial anaerobic electron transport; genome analysis of retroviruses and papillomaviruses; antibiotic resistance mechanisms; and the molecular microbiology of toxigenic clostridia. His studies on isoniazid and multidrug resistance in Mycobacterium tuberculosis, together with his pioneering work on the pathogenicity, evolution and genomics of the tubercle and leprosy bacilli, have made him an undisputed leader in the field of mycobacterial research. The findings of his research are of direct relevance to public health and disease-control in both the developing world and the industrialised nations. He has published over 250 scientific papers and review articles, and holds many patents.
Yves LeterrierYves Leterrier joined EPFL in 1993 and is a faculty member of the Materials Institute. He is a senior scientist and lecturer in the Laboratory for Processing of Advanced Composites (LPAC, previously Laboratory of Composite and Polymer Technology, LTC). Activities
2000-2005: Foundation and Chair of the Korea-Switzerland joint symposia on materials and micro-technologies2004-2008: Board member of FLEXIDIS (the European flexible display consortium) 2004-2009: Group leader on lightweight materials for Solar ImpulseSince 2008: Board member of the French Adhesion SocietySince 2000: President of the EPFL Materials Science Library commissionSince 2012: Editorial board member, Applied Surface ScienceSince 2014: Associate Editor, Frontiers in MaterialsSince 2021: Coordinator of the EPFL Minor on 'Engineering for Sustainability'
Background
1987: MS in materials science and solid state physics (INPL, France) 1991: PhD in materials science (Ecole des Mines, INPL, France) 1992: Research Associate, National Institute of Standards and Technology (NIST, USA)
Radivoje PopovicRadivoje Popovic received the Dipl. Ing. degree in engineering physics from the University of Belgrade, Yugoslavia in 1969, and the M.Sc and Dr.Sc. degrees in electronics from the University of Nis, Yugoslavia in 1974 and 1978.
From 1969 to 1981, he worked for Elektronska Industrija in Nis, Yugoslavia, where from 1978 to 1981 he was head of CMOS department. From 1982 to 1993, he was with Landis & Gyr AG, Central R&D in Zug, Switzerland, where from 1991 to 1993 he was vice president.
In 1994 Popovic joined EPFL (Swiss Federal Institute of Technology, Lausanne, Switzerland), as extraordinary professor for microtechnology systems, and became ordinary professor in 1997. He taught courses in conceptual product design, semiconductor device physics, microelectronics, optical detectors, and integrated sensors; and he was adviser of 20 PhD students. Since 2010 he is professor emeritus.
Currently, he is chief technology officer of SENIS AG (www.senis.ch).
Popovic has published a book on Hall effect devices, and is author or co-author of about 280 technical papers and 93 patent applications. He is co-founder of start-up companies Sentron AG, Sentronis AD, Senis AG, Ametes AG, and Sensima Technology SA. He is member of Swiss Academy of Engineering Sciences, Serbian Academy of Engineering Sciences, and senior member of IEEE.
Note: In publications, Radivoje Popovic is mostly cited as R.S. Popovic, Radivoje S. Popovic, or Rade Popovic; in patents, he is cited as Popovic Radivoje. 